TARSUS PHARMACEUTICALS, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | -.--% |
Chart calendar Tarsus Pharmaceuticals, Inc.
1a.AZBiZBxPYVY4m2d9uFhd4MKnAcOa4eoujE6Tnb8bD4g.TsFWIHsDKQdN11RNigo5kIGSaYb1uJBJyQf4-O15WNJOwTUDTXhSAGzjVw~a14da1f697b1b1e292ebdae2d3933cd9
Upcoming events on Tarsus Pharmaceuticals, Inc.
Past events on Tarsus Pharmaceuticals, Inc.
| 2024-06-13 12:00 | Annual General Meeting |
| 2024-06-10 14:00 | Goldman Sachs Global Healthcare Conference |
| 2024-06-05 15:00 | Jefferies Global Healthcare Conference |
| 2024-06-04 16:20 | William Blair Growth Stock Conference |
| 2024-05-15 16:55 | BofA Securities Health Care Conference |
| 2024-05-08 16:30 | Q1 2024 Earnings Call |
| 2024-05-08 16:05 | Q1 2024 Earnings Release |
| 2024-03-13 09:30 | Guggenheim Healthy Altitudes Summit - Fireside Chat |
| 2024-03-12 | Jefferies Biotech on the Bay Summit |
| 2024-03-12 15:05 | Barclays Global Healthcare Conference - Fireside Chat |
| 2024-02-27 08:00 | Q4 2023 Earnings Call |
| 2024-02-27 06:00 | Q4 2023 Earnings Release |
| 2024-02-08 13:00 | Guggenheim Healthcare Talks Biotechnology Conference |
| 2023-11-09 16:30 | Q3 2023 Earnings Call |
| 2023-11-09 16:05 | Q3 2023 Earnings Release |
| 2023-09-12 12:30 | Morgan Stanley Global Healthcare Conference |
| 2023-09-11 12:30 | H.C. Wainwright Global Investment Conference |
| 2023-08-10 16:05 | Q2 2023 Earnings Release |
| 2023-07-25 08:30 | XDEMVY™ Phase 2a Trial Results Call |
| 2023-06-22 12:00 | Annual General Meeting |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 57,0 49,1 16.22% | 25,8 25,9 -0.17% | 17,4 9,70 79.91% | 145 |
|
EBITDA Million USD | Released Forecast Spread | -26,9 -28,5 5.55% | -11,8 -15,4 23.32% | -62,4 -62,5 0.21% | -142 -138 -3.02% | -146 |
|
EBIT Million USD | Released Forecast Spread | -27,0 -28,3 4.68% | -12,2 -13,6 10.54% | -62,7 -57,0 -9.93% | -143 -144 0.6% | -145 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -26,8 -27,9 4.04% | -13,8 -14,6 5.78% | -62,1 -55,1 -12.75% | -136 -137 0.83% | -142 |
|
Net income Million USD | Released Forecast Spread | -26,8 -28,1 4.53% | -13,8 -14,9 7.06% | -62,1 -57,9 -7.22% | -136 -137 0.96% | -140 |
|
EPS USD | Released Forecast Spread | -4,32 -2,27 -90.14% | -0,67 -0,57 -16.96% | -2,52 -2,36 -6.78% | -4,62 -4,79 3.52% | -3,79 |
| Announcement Date | 31/03/21 | 14/03/22 | 13/03/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,54 2,20 -75.5% | 15,3 11,3 35.8% | 0,00 3,50 - | 10,0 10,0 0% | 2,50 3,33 -25% | 0,00 0,00 - | 1,87 0,36 418.28% | 13,1 5,92 120.73% | 27,6 17,9 54.28% | 32,4 | 39,2 | 46,1 | 52,2 | 62,0 |
|
EBITDA Million USD | Released Forecast Spread | -19,5 -23,0 15.3% | -5,13 -25,4 79.8% | -22,8 -23,4 2.51% | -15,0 -16,0 6.48% | -24,8 -22,0 -12.95% | -32,6 | -44,1 -36,1 -22.13% | -32,7 | -26,5 | |||||
|
EBIT Million USD | Released Forecast Spread | -19,5 -22,0 11.46% | -5,22 -18,3 71.51% | -22,9 -25,8 11.38% | -15,1 -18,1 16.96% | -25,0 -23,6 -5.56% | -32,8 -29,4 -11.46% | -40,9 -41,9 2.38% | -44,5 -44,9 1.11% | -37,7 -40,8 7.63% | -36,2 | -35,3 | -35,3 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -20,2 -24,5 17.55% | -5,74 -21,5 73.25% | -22,5 -28,1 19.9% | -13,6 -18,3 25.51% | -23,4 -22,9 -2.14% | -31,4 -29,1 -7.9% | -39,1 -41,9 6.62% | -41,9 -45,4 7.74% | -35,7 -41,9 14.77% | -36,1 | -37,0 | -35,8 | ||
|
Net income Million USD | Released Forecast Spread | -20,2 -22,2 8.8% | -5,74 -18,5 68.88% | -22,5 -26,0 13.33% | -13,6 -18,1 25.05% | -23,4 -23,5 0.5% | -31,4 -28,6 -9.9% | -39,1 -41,1 4.66% | -41,9 -43,7 4.08% | -35,7 -39,2 8.76% | -34,8 | -33,5 | -33,6 | ||
|
EPS USD | Released Forecast Spread | -0,98 -0,92 -6.72% | -0,24 -0,72 66.57% | -0,84 -0,97 13.7% | -0,49 -0,69 28.99% | -0,88 -0,95 6.88% | -1,17 -1,08 -8.5% | -1,28 -1,39 7.78% | -1,31 -1,32 0.76% | -1,01 -1,19 15.13% | -0,96 | -0,91 | -0,90 | -0,96 | -0,67 |
| Announcement Date | 10/05/22 | 11/08/22 | 09/11/22 | 13/03/23 | 09/05/23 | 10/08/23 | 09/11/23 | 27/02/24 | 08/05/24 | - | - | - | - | - |
More events
Past sector events for Tarsus Pharmaceuticals, Inc.
| 2024-06-21 11:28 | DEVA HOLDING: Q1 2024 Earnings Release |
| 2024-06-13 17:21 | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
| 2024-06-11 01:30 | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
| 2024-06-07 06:33 | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
| 2024-06-07 05:17 | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
| 2024-05-30 08:08 | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-05-30 07:00 | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
| 2024-05-30 02:24 | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 08:00 | FDC LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 05:26 | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TARS Stock
- Stock
- Calendar Tarsus Pharmaceuticals, Inc.
